C-BOT (CBT)

Invest in an Established IT Company at an Early Stage

Review Score
2.20/5
ICO Price
0.04 USD
Pre ICO Price
N/A
Soft Cap
150000 USD
Hard Cap
1080000 USD
Pre ICO Start Date
1 January 2022
Pre ICO End Date
1 May 2022
Start Date
2 June 2022
End Date
30 June 2022

What is C-BOT?

Chatforma is an operating company that has been operating and developing for 4 years. All this time, it has been achieving its stated goals and providing the most affordable opportunity for creating chatbots for businesses in Russia and the CIS.

Chatforma is developing this ecosystem for more efficient and inexpensive settlements, it has created its own blockchain-based internal currency called C-BOT (CBT), which can later be used to pay for the company’s services. The CBT token will appear on cryptocurrency exchanges, and as the company develops, its price will only grow. For holders of this currency there will be special benefits and privileges.

Open Website Open Whitepaper

Rating

Average Rating 44.00%
ICO Marks 44%

General Info

Symbol CBT
Category Payment Token, Platform
Pre ICO Start Date 1 January 2022
Pre ICO End Date 1 May 2022
Start Date 2 June 2022
End Date 30 June 2022
Bonus Not Available
Bounty Not Available
Platform Binance Smart Chain

Investment Info

ICO Price 1 CBT = 0.04 USD
Tokens for sale 40000000

Information displayed on CoinCheckup can be updated by the respective ICOs and/or Crypto representatives and does not present the opinion of CoinCheckup.com and/or the CoinCheckup team.

Trading and investing in digital assets is highly speculative and comes with many risks. The analysis/stats on CoinCheckup.com and it’s subsites are for informational purposes and should not be considered investment advice and or the truth. Statements and financial information on CoinCheckup.com and it’s subsites should not be construed as an endorsement or recommendation to buy, sell or hold.

Please do your own research on all of your investments carefully. Scores are based on averages of third party websites.  Past performance is no indicative of future results. Read the full disclaimer here.